Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_c3e4d0f07e2ff5ab60581f256000cc80 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_0b2bbafaecd0219ce29039ce18585fb2 |
classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A23V2200-308 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A23V2002-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/Y02P20-55 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D403-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D401-14 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-5355 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A23L33-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-5355 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D403-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A23L33-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00 |
filingDate |
2019-05-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9536f0f4aa3c275781a19edabdf997c7 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_95c5cbbdd7d2b456fcb8916e2cad65cc http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_56dde178e9cbf3fb08316c3b0dea460d http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e5a84a67fd950e2859ddc018acb2b437 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e54c741ef279df37cbe17d772088fe2c http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8ec173ed717aa8b1e3f0f019888c00bc http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4fb35eb00f82cd7a15b09feb3745bc12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f8654d06b73a4641564a81ae67379473 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_be97bbaa6a339aa3a24d5ad300bd765c |
publicationDate |
2020-12-09-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
KR-20200137087-A |
titleOfInvention |
Novel 4-substituent-N-(1-substituent-1H-pyrazol-4-yl)-5-morpholinopyrimidin-2-amine derivatives and use thereof |
abstract |
The present invention is a novel 4-substituted-N-(1-substituted-1H-pyrazol-4-yl)-5-morpholinopyrimidin-2-amine derivative compound or a pharmaceutically acceptable salt thereof, effective A pharmaceutical composition for preventing or treating JAK3-related diseases, and the pharmaceutical composition comprising as an ingredient relates to a method for preventing or treating JAK3-related diseases using. |
priorityDate |
2019-05-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |